What about non-alcoholic fatty liver disease as a new criterion to define metabolic syndrome?
about
Association between white blood cell count and non-alcoholic fatty liver disease in urban Han Chinese: a prospective cohort studyNovel nutraceutic therapies for the treatment of metabolic syndromeManagement of diabolical diabetes mellitus and periodontitis nexus: Are we doing enough?Impact of obesity treatment on gastroesophageal reflux diseaseDocosahexaenoic Acid Levels in Blood and Metabolic Syndrome in Obese Children: Is There a Link?Could metabolic syndrome lead to hepatocarcinoma via non-alcoholic fatty liver disease?Lessons from mouse models of high-fat diet-induced NAFLDTargeting inflammation in diabetes: Newer therapeutic optionsThe Global Nonalcoholic Fatty Liver Disease Epidemic: What a Radiologist Needs to Know.Low serum amylase and obesity, diabetes and metabolic syndrome: A novel interpretationMetabolic aspects of adult patients with nonalcoholic fatty liver diseaseGlucagon-like peptide-1 receptor agonists favorably address all components of metabolic syndromeDiabetic foot syndrome: Immune-inflammatory features as possible cardiovascular markers in diabetesNon-alcoholic fatty liver disease: need for a balanced nutritional sourceRadiologic evaluation of nonalcoholic fatty liver diseaseEffect of a counseling-supported treatment with the Mediterranean diet and physical activity on the severity of the non-alcoholic fatty liver disease.Carotid intima-media thickness is predicted by combined eotaxin levels and severity of hepatic steatosis at ultrasonography in obese patients with Nonalcoholic Fatty Liver DiseaseInhibition of key enzymes linked to type 2 diabetes and sodium nitroprusside induced lipid peroxidation in rats' pancreas by phenolic extracts of avocado pear leaves and fruit.Surgical treatment of nonalcoholic fatty liver disease in severely obese patientsCould the improvement of obesity-related co-morbidities depend on modified gut hormones secretion?Alimentary regimen in non-alcoholic fatty liver disease: Mediterranean diet.Plasma levels of homocysteine and cysteine increased in pediatric NAFLD and strongly correlated with severity of liver damage.Comparison of serum ferritin and vitamin d in association with the severity of nonalcoholic Fatty liver disease in korean adults.Clinical features and computed tomography characteristics of non-Klebsiella pneumoniae liver abscesses in elderly (>65 years) and nonelderly patients.Development of non-alcoholic fatty liver disease scoring system among adult medical check-up patients: a large cross-sectional and prospective validation study.The Impacts of Obesity and Metabolic Abnormality on Carotid Intima-Media Thickness and Non-Alcoholic Fatty Liver Disease in Children from an Inland Chinese City.Integrated Haematological Profiles of Redox Status, Lipid, and Inflammatory Protein Biomarkers in Benign Obesity and Unhealthy Obesity with Metabolic Syndrome.Non-alcoholic fatty liver disease, diet and gut microbiota.Aryl hydrocarbon receptor deficiency protects mice from diet-induced adiposity and metabolic disorders through increased energy expenditure.Utilization of antihypertensive drugs in obesity-related hypertension: a retrospective observational study in a cohort of patients from Southern Italy.Epigenetic Modifications in the Biology of Nonalcoholic Fatty Liver Disease: The Role of DNA Hydroxymethylation and TET ProteinsOne-Year Mortality after Traumatic Brain Injury in Liver Cirrhosis Patients--A Ten-Year Population-Based Study.Altered hepatic lipid metabolism in mice lacking both the melanocortin type 4 receptor and low density lipoprotein receptorGeneral and Abdominal Adiposity and Risk of Death in HBV Versus Non-HBV Carriers: A 10-Year Population-based Cohort Study.Metabolic Health Is More Important than Obesity in the Development of Nonalcoholic Fatty Liver Disease: A 4-Year Retrospective Study.Fatty liver index vs waist circumference for predicting non-alcoholic fatty liver diseaseRole of γ-glutamyl transferase levels in prediction of high cardiovascular risk among patients with non-alcoholic fatty liver diseaseRisks of borderline liver enzyme abnormalities to the incidence of impaired fasting glucose and diabetes mellitus: a 7 year follow up study of workersDose-Response Relationship between Alanine Aminotransferase Levels within the Reference Interval and Metabolic Syndrome in Chinese Adults.The association between liver enzymes and risk of type 2 diabetes: the Namwon study.
P2860
Q24658538-84D47C94-79A5-494C-A274-45C2A4D8CF9BQ26748558-76227CB7-377B-40B0-AAEE-1EB9B141A501Q26766648-BF71861A-3525-437F-8CD3-1EDF6F7845E5Q26773208-8633FC94-641B-4588-A867-613F2A815206Q26797346-38C27B82-9F71-4F99-9091-45E5891734E5Q26824893-D2F933D2-2719-4516-ADA6-2F1003BF0FE7Q26829532-F486A8FC-8E3E-46ED-98FB-9BC22E29F84AQ26852726-6DAFDA65-4386-4556-8A39-A36DA5D02606Q27008277-AC52CBFE-4CC8-4B4E-8742-478C5ABF3DF5Q28066021-F55145C0-163A-4C75-9A63-EDC5433EBE42Q28067490-DE5AD7B8-F1E3-4115-AD7C-9618DE26C0D2Q28070416-956940CD-6394-4A68-B474-A7065ABD40F0Q28082521-0DDE11B9-45AF-4AE6-88AA-8DBDD49F001AQ28248994-186412F2-5F81-4BE7-A4D9-D11A837B3E3BQ30436162-6B76A813-B5F0-4A9B-9821-9C0A7FF911D8Q33652021-5C03AF8F-DA17-4844-A3DC-B6C6C38F8ECBQ34275915-2D3E8DAF-6448-40A3-A015-530842059035Q34350792-CF2E6B8E-2322-4806-9FCF-2EE984FCD7A2Q34446294-D6C54A16-C049-4A08-8CC4-AD1F8B04E441Q34589770-E6B16DC2-0AA9-4A9F-AFB3-E879C7D92CCFQ34647390-6E132F9F-9016-4DE3-BFC7-20DA396658FDQ34685694-DD18278A-3DA3-4704-89BA-BFFED314B292Q34839464-D52A495F-870A-4FA9-AA25-4AC39085E99BQ35086113-0484FD59-D620-436F-8441-9BC278B57330Q35541683-690309E6-197E-41E8-A48A-729211D55B7CQ35667170-0610186F-DC5E-4528-A263-C342915869E8Q35673707-3561BF0D-516D-442C-BF9D-2827D18E4CEBQ35728214-D4819DD0-6F67-41C1-95D1-58A932F9CCBEQ35920926-60C86AE2-99EF-4E00-959F-09795C651F2DQ35958750-A07E42B9-3076-43ED-9F5B-426853B244A8Q36194904-BE187F0E-E658-4623-988F-0D6E16E60F19Q36195323-486E97F0-71D8-45B1-B3FB-251E5A7C0FC1Q36282638-0A4819EC-E9D2-43D0-B52A-BCD99BB242D2Q36477998-D60F5D76-3116-4921-883B-04FE60245453Q36489160-CB5ED4F6-44F4-4301-AFE5-50CE09803260Q36656622-E7F61AD9-5D76-4067-A161-382AB1F3B946Q36769687-827DC94C-2556-4230-8714-CD5F79A40DF4Q36774697-77AA9A10-AA40-474C-BF44-682B58928069Q37438315-5DC84A3A-D256-493B-8B2C-2054BA1B093DQ37568824-A615BA9C-7020-45CC-BC4F-91A7EFE94B1B
P2860
What about non-alcoholic fatty liver disease as a new criterion to define metabolic syndrome?
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
What about non-alcoholic fatty ...... to define metabolic syndrome?
@en
type
label
What about non-alcoholic fatty ...... to define metabolic syndrome?
@en
prefLabel
What about non-alcoholic fatty ...... to define metabolic syndrome?
@en
P2860
P356
P1476
What about non-alcoholic fatty ...... to define metabolic syndrome?
@en
P2093
Carmine Finelli
Giovanni Tarantino
P2860
P304
P356
10.3748/WJG.V19.I22.3375
P407
P577
2013-06-01T00:00:00Z